Meihao Medical Group Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	84.45	74.68	73.51	127.41	105.32	84.56
Revenue Growth (YoY)	16.77%	1.59%	-42.30%	20.98%	24.55%	1.68%
Cost of Revenue	53.81	47.7	40.86	49.16	38.39	33.94
Gross Profit	30.65	26.98	32.66	78.25	66.93	50.62
Selling, General & Admin	56.09	59.53	43.6	35.71	22.6	25.18
Other Operating Expenses	-	-	-	-	-	0.07
Operating Expenses	56.1	59.54	43.6	35.69	22.29	25.3
Operating Income	-25.45	-32.56	-10.95	42.56	44.64	25.31
Interest Expense	-1.62	-1.62	-1.63	-1.89	-2.47	-1.83
Interest & Investment Income	3.7	3.7	4.97	1.65	1.21	0.45
Currency Exchange Gain (Loss)	0.11	0.11	0.06	-	-	-
Other Non Operating Income (Expenses)	-1.18	0.22	0.07	-0.84	0.03	-0.13
EBT Excluding Unusual Items	-24.43	-30.15	-7.48	41.49	43.41	23.8
Other Unusual Items	0	0	0.32	-1.28	0.26	0.39
Pretax Income	-24.43	-30.15	-7.16	40.2	43.67	24.19
Income Tax Expense	2.99	2.48	6.45	11.63	11.49	9.21
Earnings From Continuing Operations	-27.42	-32.62	-13.61	28.57	32.18	14.98
Minority Interest in Earnings	0.07	0.2	0.01	-0.11	-0.11	-0.08
Net Income	-27.36	-32.42	-13.59	28.46	32.07	14.9
Net Income to Common	-27.36	-32.42	-13.59	28.46	32.07	14.9
Net Income Growth	-	-	-	-11.27%	115.19%	-3.41%
Shares Outstanding (Basic)	561	582	600	457	450	-
Shares Outstanding (Diluted)	561	582	600	457	450	-
Shares Change (YoY)	-6.41%	-3.01%	31.18%	1.64%	-	-
EPS (Basic)	-0.05	-0.06	-0.02	0.06	0.07	-
EPS (Diluted)	-0.05	-0.06	-0.02	0.06	0.07	-
EPS Growth	-	-	-	-12.70%	-	-
Free Cash Flow	-9.87	-16.05	0.05	24.17	28.6	24.06
Free Cash Flow Per Share	-0.02	-0.03	-	0.05	0.06	-
Dividend Per Share	-	-	0.009	-	-	-
Gross Margin	36.29%	36.12%	44.42%	61.41%	63.55%	59.86%
Operating Margin	-30.14%	-43.60%	-14.89%	33.41%	42.38%	29.94%
Profit Margin	-32.39%	-43.42%	-18.49%	22.34%	30.45%	17.63%
Free Cash Flow Margin	-11.69%	-21.49%	0.07%	18.97%	27.16%	28.46%
EBITDA	-19.49	-26.07	-3.66	48.69	49.13	29.2
EBITDA Margin	-23.08%	-34.91%	-4.98%	38.21%	46.65%	34.53%
D&A For EBITDA	5.96	6.49	7.29	6.13	4.49	3.89
EBIT	-25.45	-32.56	-10.95	42.56	44.64	25.31
EBIT Margin	-30.14%	-43.60%	-14.89%	33.41%	42.38%	29.94%
Effective Tax Rate	-	-	-	28.93%	26.31%	38.08%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.